<code id='83D10A25F8'></code><style id='83D10A25F8'></style>
    • <acronym id='83D10A25F8'></acronym>
      <center id='83D10A25F8'><center id='83D10A25F8'><tfoot id='83D10A25F8'></tfoot></center><abbr id='83D10A25F8'><dir id='83D10A25F8'><tfoot id='83D10A25F8'></tfoot><noframes id='83D10A25F8'>

    • <optgroup id='83D10A25F8'><strike id='83D10A25F8'><sup id='83D10A25F8'></sup></strike><code id='83D10A25F8'></code></optgroup>
        1. <b id='83D10A25F8'><label id='83D10A25F8'><select id='83D10A25F8'><dt id='83D10A25F8'><span id='83D10A25F8'></span></dt></select></label></b><u id='83D10A25F8'></u>
          <i id='83D10A25F8'><strike id='83D10A25F8'><tt id='83D10A25F8'><pre id='83D10A25F8'></pre></tt></strike></i>

          knowledge

          knowledge

          author:knowledge    Page View:2786

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

          STAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live.

          advertisement

          Sponsor Introduction

          • Ashwin Athri, EVP, strategy, innovation, & partnerships, Precision AQ

          Featured Speakers

          • Angus Chen, cancer reporter, STAT
          • Adam Feuerstein, senior writer, biotech, STAT
          • Matthew Herper, senior writer, medicine; editorial director of events, STAT
          • Katherine MacPhail, programmer, editorial events, STAT (moderator)

          Sponsored By

          focus

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Adam's Biotech Scorecard: Do Sarepta's exon
          Adam's Biotech Scorecard: Do Sarepta's exon

          ThisistheonlineeditionofAdam’sBiotechScorecard,asubscriber-onlynewsletter.STAT+subscriberscansignuph

          read more
          At least 13 dead in Texas as scorching temps continue
          At least 13 dead in Texas as scorching temps continue

          1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

          read more

          Bispecific antibodies are next new thing in cancer immunotherapy

          IllustrationofaBiTE,Amgen'sbispecificantibodiesAmgenIncancerimmunotherapythesedays,technologyisadvan